What is Sylfirm?
Sylfirm uses SR3 technology, the world’s first developed technology in Silicon Valley, USA. It applies RP, a new technology that reacts only to abnormal blood vessels and basement membrane.
- Selective treatment result in self limitation of abnormal blood vessels, normalization of VEGF overproduction.
- Remodeling of basement membrane, and dermal rejuvenation.